DK0877941T3 - Fremgangsmåde til masseforøgelse af en population eller subpopulation af celler - Google Patents

Fremgangsmåde til masseforøgelse af en population eller subpopulation af celler

Info

Publication number
DK0877941T3
DK0877941T3 DK96943478T DK96943478T DK0877941T3 DK 0877941 T3 DK0877941 T3 DK 0877941T3 DK 96943478 T DK96943478 T DK 96943478T DK 96943478 T DK96943478 T DK 96943478T DK 0877941 T3 DK0877941 T3 DK 0877941T3
Authority
DK
Denmark
Prior art keywords
population
particles
sample
subpopulation
eliminated
Prior art date
Application number
DK96943478T
Other languages
English (en)
Inventor
Norma S Kenyon
Thomas R Russell
Camillo Ricordi
Robert K Zwerner
Original Assignee
Biotransplant Inc
Univ Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotransplant Inc, Univ Miami filed Critical Biotransplant Inc
Application granted granted Critical
Publication of DK0877941T3 publication Critical patent/DK0877941T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/5375Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by changing the physical or chemical properties of the medium or immunochemicals, e.g. temperature, density, pH, partitioning
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553Metal or metal coated
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • G01N33/56972White blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK96943478T 1995-11-13 1996-11-05 Fremgangsmåde til masseforøgelse af en population eller subpopulation af celler DK0877941T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55826895A 1995-11-13 1995-11-13
PCT/US1996/017531 WO1997018473A1 (en) 1995-11-13 1996-11-05 Method and apparatus for bulk enrichment of a population or subpopulation of cells

Publications (1)

Publication Number Publication Date
DK0877941T3 true DK0877941T3 (da) 2003-05-05

Family

ID=24228865

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96943478T DK0877941T3 (da) 1995-11-13 1996-11-05 Fremgangsmåde til masseforøgelse af en population eller subpopulation af celler

Country Status (10)

Country Link
US (1) US6004743A (da)
EP (1) EP0877941B1 (da)
JP (1) JP2000500337A (da)
AT (1) ATE233406T1 (da)
CA (1) CA2236871A1 (da)
DE (1) DE69626418T2 (da)
DK (1) DK0877941T3 (da)
ES (1) ES2194125T3 (da)
PT (1) PT877941E (da)
WO (1) WO1997018473A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19710496A1 (de) * 1997-03-13 1998-09-17 Boehringer Mannheim Gmbh Verfahren zum Nachweis antigenspezifischer T-Zellen nach Anreicherung von mononukleären Zellpopulationen
US6623982B1 (en) * 1999-07-12 2003-09-23 Immunivest Corporation Increased separation efficiency via controlled aggregation of magnetic nanoparticles
US7316932B2 (en) * 2001-10-01 2008-01-08 Stemcell Technologies Inc. Method for separating cells
US9435799B2 (en) 2002-07-31 2016-09-06 Janssen Diagnostics, Inc. Methods and reagents for improved selection of biological materials
DE10323901A1 (de) * 2003-05-26 2005-01-05 Institut Virion/Serion Gmbh Verfahren und Testmittel zur Untersuchung und/oder zum Nachweis von Biomolekülen und/oder Wirkstoffen in Flüssigkeitsproben
US9790539B2 (en) 2004-06-30 2017-10-17 Russell Biotech, Inc. Methods and reagents for improved selection of biological molecules
EP1861710A4 (en) * 2005-03-03 2008-07-23 Univ North Dakota SURFACES COATED WITH TARGET-LINKED FLUORESCENT COMPOUNDS FOR DETECTING TARGET ELEMENTS
WO2007126151A1 (ja) * 2006-04-28 2007-11-08 Hitachi Maxell, Ltd. 機能性粒子およびそれを用いた標的物質の分離方法
US8895291B2 (en) 2010-10-08 2014-11-25 Terumo Bct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
EP2745115B1 (de) * 2011-08-19 2016-05-18 Protagen AG Neues verfahren zur diagnostik von hochaffinen bindern und markersequenzen
EP2597153B1 (en) 2011-11-25 2016-10-05 Miltenyi Biotec GmbH Cell separation method
JP6612227B2 (ja) 2013-11-16 2019-11-27 テルモ ビーシーティー、インコーポレーテッド バイオリアクターにおける細胞増殖
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
WO2016049421A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
WO2017205667A1 (en) 2016-05-25 2017-11-30 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
WO2018184028A2 (en) 2017-03-31 2018-10-04 Terumo Bct, Inc. Cell expansion
US12227548B2 (en) 2018-11-19 2025-02-18 Dana-Farber Cancer Institute, Inc. Use of IRE1α-XBP1 signaling pathway biomarkers for modulating immune responses
GB2619893A (en) 2021-03-23 2023-12-20 Terumo Bct Inc Cell capture and expansion
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928143A (en) * 1972-02-23 1975-12-23 Robert W Coughlin Method of carrying out enzyme-catalyzed reactions
US4115535A (en) * 1977-06-22 1978-09-19 General Electric Company Diagnostic method employing a mixture of normally separable protein-coated particles
US4487700A (en) * 1983-02-18 1984-12-11 Technicon Instruments Corporation Method and apparatus for separating lymphocytes from anticoagulated blood
US4752563A (en) * 1985-11-19 1988-06-21 Coulter Corporation Monoclonal antibody for recovery of leukocytes in human peripheral blood and method of recovery employing said monoclonal antibody
US5229268A (en) * 1986-07-14 1993-07-20 Abbott Laboratories Method for diagnostic immunoassay by solid phase separation
NO162946C (no) * 1987-08-21 1990-03-14 Otto Soerensen Anordning for magnetisk separasjon av celler.
US5238812A (en) * 1987-03-13 1993-08-24 Coulter Corporation Method and apparatus for rapid mixing of small volumes for enhancing biological reactions
ATE81724T1 (de) * 1987-11-09 1992-11-15 Becton Dickinson Co Verfahren zur analyse haematopoietischer zellen in einer probe.
US5256532A (en) * 1988-05-02 1993-10-26 Zynaxis Technologies, Inc. Methods, reagents and test kits for determination of subpopulations of biological entities
US5576185A (en) * 1994-04-15 1996-11-19 Coulter Corporation Method of positive or negative selection of a population or subpopulation of a sample utilizing particles and gravity sedimentation
US5474687A (en) * 1994-08-31 1995-12-12 Activated Cell Therapy, Inc. Methods for enriching CD34+ human hematopoietic progenitor cells

Also Published As

Publication number Publication date
CA2236871A1 (en) 1997-05-22
PT877941E (pt) 2003-07-31
WO1997018473A1 (en) 1997-05-22
EP0877941B1 (en) 2003-02-26
EP0877941A1 (en) 1998-11-18
JP2000500337A (ja) 2000-01-18
DE69626418T2 (de) 2003-11-13
ES2194125T3 (es) 2003-11-16
ATE233406T1 (de) 2003-03-15
HK1016261A1 (en) 1999-10-29
DE69626418D1 (de) 2003-04-03
US6004743A (en) 1999-12-21

Similar Documents

Publication Publication Date Title
PT877941E (pt) Metodo para enriquecimento em volume de uma populacao ou subpopulacao de celulas
ATE292282T1 (de) Verfahren zur zellseparation unter verwendung von immunorosetten
MXPA01013107A (es) Metodo para separar celulas de una muestra.
DK1078263T3 (da) Fremgangsmåde til direkte selektion af antigen-specifikke T-celler
JP2003501629A5 (da)
ES2145030T3 (es) Preparacion de acido nucleico a partir de celulas mononucleares.
ATE536550T1 (de) Halbleiter nanokristalle enthaltende transfektibare mizellen
DE69332926D1 (de) Kontinuierliches zentrifugationsverfahren zum abtrennen von biologischen komponenten aus heterogenen zellpopulationen
AU6050701A (en) Nucleic acid isolation
CA2279476A1 (en) Novel antibody composition for isolating human cells from human-murine chimeric hematopoietic cell suspensions
DE69636564D1 (de) Verfahren zur freisetzung von magnetischen teilchen, die an zelloberflächen gebunden sind
ATE280948T1 (de) Verfahren zur auswahl einer population oder subpopulation einer probe unter verwendung von partikel-und schwerkraft -sedimentation
ATE75317T1 (de) Monoklonaler antikoerper zur wiedergewinnung von leukozyten in menschlichem peripherblut und gewinnungsverfahren unter verwendung dieses antikoerpers.
WO2004020597A3 (en) Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
WO2000047762A3 (en) Enriched central nervous system cell populations
Kumar et al. Cell Separation: Fundamentals, Analytical and Preparative Methods
ATE120796T1 (de) Trennungsverfahren zum trennen von hämatopoeitischen vorläuferzellen.
AU5326198A (en) Synthetic biepitope compounds which can be used as standards in the biological assays of troponin I
AU1459392A (en) Method and apparatus for screening microscopic cells utilizing polarized light scatter techniques
ATE180893T1 (de) Chromatographiematerial
MX9604813A (es) Metodo de seleccion de una poblacion o subpoblacion de una muestra.
ZA866956B (en) Methods for utilizing cell lines which lack human class ii histocompatibility antigens
EP0089826A3 (en) Method of enumerating serologically selected cell populations
Harmon et al. A global analysis of the oxygen isotope composition of basalts: evidence for low and high 180 reservoirs in the mantle
McQueen et al. 181-P: A rapid method to enrich specific lymphocyte populations (T cells, B cells, total lymphocytes) from whole blood